TY  - JOUR 
AU  - Jorge Fernández, Monica
PY  - 2013
SN  - 0959-8049
UR  - http://hdl.handle.net/20.500.11940/2282
LA  - eng
TI  - Bevacizumab plus capecitabine and oxaliplatin (XELOX) as first-line treatment for elderly patients with metastatic colorectal cancer (mCRC) suitable for combination chemotherapy: Efficacy and safety findings from the phase II BECOX study (GEMCAD Study Gro
T2  - EUROPEAN JOURNAL OF CANCER
M2  - S553
VL  - 49
ER  -